A combination of inhibitors of glycolysis, glutaminolysis and

6-Diazo-5-oxo-L-norleucine cancer metabolism chemokines lonidamine orlistat small interfering RNA blockade

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 19 04 2019
accepted: 24 09 2019
entrez: 3 12 2019
pubmed: 4 12 2019
medline: 4 12 2019
Statut: ppublish

Résumé

Lonidamine, 6-Diazo-5-oxo-L-norleucine (DON) and orlistat are well known inhibitors of glycolysis, glutaminolysis and of

Identifiants

pubmed: 31788130
doi: 10.3892/ol.2019.11008
pii: OL-0-0-11008
pmc: PMC6865793
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6909-6916

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019, Spandidos Publications.

Références

Front Oncol. 2018 Aug 13;8:284
pubmed: 30151352
Anticancer Res. 2005 Sep-Oct;25(5):3581-4
pubmed: 16101183
Cell Metab. 2016 Jan 12;23(1):27-47
pubmed: 26771115
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13063-8
pubmed: 20616008
Br J Cancer. 2016 Jun 14;114(12):1343-51
pubmed: 27149649
Tumour Biol. 2018 Nov;40(11):1010428318810059
pubmed: 30419802
PLoS One. 2011;6(12):e28842
pubmed: 22205974
Int J Colorectal Dis. 2013 Nov;28(11):1479-87
pubmed: 23649168
Cancer Res. 2001 Mar 1;61(5):2200-6
pubmed: 11280787
Oncogene. 2006 Aug 7;25(34):4777-86
pubmed: 16892090
Cancer Res. 2004 Mar 15;64(6):2070-5
pubmed: 15026345
Biochem Med (Zagreb). 2011;21(3):264-75
pubmed: 22420240
Virchows Arch. 2019 Apr;474(4):407-420
pubmed: 30374798
Int J Mol Sci. 2018 Aug 16;19(8):null
pubmed: 30115896
PLoS One. 2013 Dec 18;8(12):e82300
pubmed: 24367513
Gastroenterology. 2015 Sep;149(3):692-704
pubmed: 25962936
Oncotarget. 2016 May 10;7(19):27394-407
pubmed: 27034164
Cancer Res. 2014 Dec 1;74(23):6845-55
pubmed: 25297635
Trends Biochem Sci. 2010 Aug;35(8):427-33
pubmed: 20570523
Onco Targets Ther. 2018 Oct 23;11:7333-7343
pubmed: 30425523
Methods Enzymol. 2009;460:105-21
pubmed: 19446722
Cell. 2002 Apr;109 Suppl:S81-96
pubmed: 11983155
Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2481-2484
pubmed: 30255816
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Oncotarget. 2016 Jul 26;7(30):48335-48345
pubmed: 27340784
Oncol Rep. 2015 Sep;34(3):1533-42
pubmed: 26134042
Eur J Cancer. 2012 Sep;48(14):2244-51
pubmed: 22197219
Am J Cancer Res. 2017 May 01;7(5):1107-1135
pubmed: 28560061
Oncol Lett. 2017 Mar;13(3):1905-1910
pubmed: 28454342
PLoS One. 2017 Mar 3;12(3):e0173303
pubmed: 28257497
Redox Biol. 2017 Aug;12:833-842
pubmed: 28448945
Front Oncol. 2017 Jan 31;7:3
pubmed: 28197395
Neoplasia. 2016 Jan;18(1):49-59
pubmed: 26806351

Auteurs

Alejandro Schcolnik-Cabrera (A)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.

Guadalupe Dominguez-Gómez (G)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.

Alma Chávez-Blanco (A)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.

Marisol Ramírez-Yautentzi (M)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.

Rocío Morales-Bárcenas (R)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.

José Chávez-Díaz (J)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.

Lucía Taja-Chayeb (L)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.

Alfonso Dueáas-González (A)

Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico.
Biomedical Research Unit in Cancer, Biomedical Research Institute, National Autonomous University of Mexico, Mexico City 14080, Mexico.

Classifications MeSH